loader
Please Wait
Applying Filters...
FDA_Warning_Letters, Import_Alerts_&_EU_Non-Compliances_in_2019
X

pmc-isochem-Default-Wallpaper
Filters Filter
×
FILTER DATA :

filter

Capsule

Granule / Pellet

Softgel Capsule

Tablet

Topical Film

Transdermal Patch

Orodispersible Tablet

Solution

filter

GERMANY

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier

Applications: For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

Dosage Form: Capsule, Tablet, Topical Film, Transdermal Patch

Category: Controlled & Modified Release, Direct Compression, Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specifications: Not Available

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier

Applications: pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Ingredient(s): Polyvinyl Acetate, Sodium Lauryl Sulfate

Dosage Form: Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

Category: Coating Systems & Additives, Controlled & Modified Release, Taste Masking

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specifications: Not Available

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier

Applications: Ready-to-use ODT solution with superior mouthfeel.

Ingredient(s): Crospovidone, Mannitol, Polyvinyl Acetate

Dosage Form: Orodispersible Tablet

Category: Chewable & Orodispersible Aids, Direct Compression, Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: 90 % mannitol, 5 % crospovidone, 5 % polyvinyl acetate

Technical Specifications: Not Available

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier

Applications: Increase solubility and bioavailability, Ideal for hot melt extrusion (HME)

Ingredient(s): polyethylene glycol, Polyvinyl Acetate

Dosage Form: Solution, Tablet, Topical Film, Transdermal Patch

Category: Controlled & Modified Release, Granulation, Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

Technical Specifications: Not Available

PharmaCompass >>

First
Previous
Next
Last